Cabozantinib is undoubtedly an oral multikinase inhibitor authorized for your treatment of State-of-the-art renal cell carcinoma. Radiological reaction evaluation may very well be complicated mainly because, like other multikinase inhibitors, cabozantinib triggers vascularization reduction and, in the lung, it could be associated with metastasis ca